Operator of an artificial intelligence (AI) based new drug development platform intended to discover high-potency drugs. The company's platform accelerates the development of therapies by combining sc...

Healthcare
Seoul, South Korea
Founded 2021
9 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$12M
Last Round
N/A

Get the full picture

Create a free account to unlock Aigen Sciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required